Systematic review evaluates anti-IL-5 and anti-IL-5Rα biologics for eosinophilic respiratory and systemic diseases.
New Asthma Drugs Target the Real Troublemakers Hiding in Your Lungs
This systematic review examined the use of anti-IL-5 and anti-IL-5Rα biologics in patients with severe eosinophilic asthma, chronic rhinosin…
New asthma drugs target the specific immune cells causing swelling and mucus in severe asthma, nasal polyps, and rare eosinophil diseases.
Systematic review suggests biologics may improve outcomes in chronic rhinosinusitis with nasal polyps
Can newer biologic drugs help people with chronic sinus polyps breathe easier?
A systematic review of clinical trials and real-world data in patients with chronic rhinosinusitis with nasal polyps found biologics may enh…
Newer biologic drugs can improve quality of life for chronic sinus polyps patients, reduce steroid use, and lower the need for sinus surgery…